Cargando…
Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer
The combination of Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy (ET) is the standard of care for hormone receptor-positive (HR + ), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). Currently, there are no robust biomarkers that can p...
Autores principales: | Khorrami, Mohammadhadi, Viswanathan, Vidya Sakar, Reddy, Priyanka, Braman, Nathaniel, Kunte, Siddharth, Gupta, Amit, Abraham, Jame, Montero, Alberto J., Madabhushi, Anant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421862/ https://www.ncbi.nlm.nih.gov/pubmed/37567880 http://dx.doi.org/10.1038/s41523-023-00574-7 |
Ejemplares similares
-
Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer
por: Jain, Prantesh, et al.
Publicado: (2021) -
Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al
por: Viswanathan, Vidya Sankar, et al.
Publicado: (2022) -
A tumor vasculature–based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors
por: Alilou, Mehdi, et al.
Publicado: (2022) -
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
por: Braman, Nathaniel M., et al.
Publicado: (2017) -
Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
por: Braman, Nathaniel M., et al.
Publicado: (2017)